Article Main
In Vitro Antimicrobial and Cytotoxic Activities of Verbena officinalis L. Extracts: Preliminary Screening and Dose–Response Evaluation in MCF-7 Breast Cancer Cells Antimicrobial and Cytotoxic Activities
Published: 2026-08-31
Abstract
Background: Verbena officinalis L. is a medicinal plant with a variety of secondary metabolites and described biological activities. Although previous investigations have demonstrated antimicrobial and antiproliferative properties of preparations derived from V. officinalis, biological responses may vary considerably depending on polarity of the solvent, extraction conditions and experimental models. Further evaluation of various plant extracts could help to understand their possible biological activities.
Objective: The objective of this study was to evaluate concentration dependent cytotoxic responses of MCF-7 human breast cancer cells after exposure to hexane and ethyl acetate fractions and to study the antimicrobial activity of aqueous and methanolic extracts of V. officinalis against selected microorganisms. Materials and Methods: Aqueous and methanolic extracts were prepared from the leaves and stems of V. officinalis. Antimicrobial activity was assessed using the agar-well diffusion method against Staphylococcus aureus, Streptococcus sobrinus, Klebsiella pneumoniae, and Candida albicans at nominal extract concentrations of 12.5%, 25%, 50%, and 100%. The cytotoxic responses of MCF-7 cells were evaluated using the MTT assay following exposure to hexane and ethyl acetate fractions at concentrations ranging from 10 to 300 µg/mL, with vincristine included as a reference treatment. The available data were evaluated using descriptive statistics and exploratory concentration–response modeling. Results: The aqueous extract produced inhibition zones of 13–14 mm against S. aureus and 13–15 mm against S. sobrinus at the two highest tested concentrations. The methanolic extract produced inhibition zones of 13–15 mm against S. sobrinus. No measurable inhibition was reported against K. pneumoniae or C. albicans. In the MTT assay, both plant fractions demonstrated concentration-associated inhibition of MCF-7 cellular metabolic activity. At 300 µg/mL, mean inhibition reached 63.6% for the hexane fraction and 49.6% for the ethyl acetate fraction, compared with 93.9% for vincristine. Calculated IC50 values IC50 values were 234.99 µg/mL for hexane, 274.10 µg/mL for ethyl acetate, and 21.25 µg/mL for vincristine. Exploratory reanalysis yielded different apparent IC50 estimates, particularly for the ethyl acetate fraction. Conclusion: It was shown that under the conditions of the experiment the preparations of verbena officinalis had a selective antimicrobial action and inhibited the metabolic activity of MCF-7 cells depending on the concentration. Overall, the hexane fraction showed more inhibition than the ethyl acetate fraction. These preliminary results are an incentive for further standardized studies to assess the biological significance and repeatability of the responses found.
Keywords
References
- 1. Kubica P, Szopa A, Dominiak J, Luczkiewicz M, Ekiert H. Verbena officinalis (common vervain)—a review on the investigations of this medicinally important plant species. Planta Med. 2020;86(17):1241–1257. doi: 10.1055/a-1232-5758.
- 2. Encalada MA, Rehecho S, Ansorena D, Astiasarán I, Cavero RY, Calvo MI. Antiproliferative effect of phenylethanoid glycosides from Verbena officinalis L. on colon cancer cell lines. LWT Food Sci Technol. 2015;63(2):1016–1022. doi: 10.1016/j.lwt.2015.03.065.
- 3. Kubica P, Kokotkiewicz A, Malinowska M, et al. Phenylpropanoid glycoside and phenolic acid profiles and biological activities of biomass extracts from different types of Verbena officinalis microshoot cultures and soil-grown plant. Antioxidants (Basel). 2022;11(2):409. doi: 10.3390/antiox11020409.
- 4. Nisar R, Adhikary S, Ahmad S, Alam MA. In vitro antimelanoma properties of Verbena officinalis fractions. Molecules. 2022;27(19):6329. doi: 10.3390/molecules27196329.
- 5. Zhang Z, Pan T. HPLC determination of chlorogenic acid in Verbena officinalis L. extract and its in-vitro antibacterial activity. Biomed Res. 2017;28(9):3996–4001.
- 6. Shao R, Zhou X, Zhao R, Yanamandra AK, Xing Z, Dai X, et al. Verbena officinalis L. regulates killing efficiency of natural killer cells. bioRxiv. 2021. doi: 10.1101/2021.10.22.465498.
- 7. Kubica P, Szopa A, Kokotkiewicz A, et al. Production of verbascoside, isoverbascoside and phenolic acids in callus, suspension, and bioreactor cultures of Verbena officinalis and biological properties of biomass extracts. Molecules. 2020;25(23):5609. doi: 10.3390/molecules25235609.
- 8. Nasr A, Abdelaal M, El-Fattah GA. Phytochemical analysis and biological activity of Verbena officinalis L. in two habitats. 2023;65(4):6–9. doi: 10.21608/mjb.2023.449549.
- 9. Akkaya H, Özmaldar A. In silico trial approaches between phytochemical composition of Verbena officinalis and liver cancer targets. Ankara Üniversitesi Eczacılık Fakültesi Dergisi. 2024;48(3). doi: 10.33483/jfpau.1417289.
- 10. Stepanova SI, Shtrygol SY, Tovchyha OV, Demeshko OV. Clinical and pharmacological aspects of vervain (Verbena officinalis L.) using in the treatment of respiratory system diseases (literature review). Farmatsevtychnyi Zhurnal. 2023. doi: 10.32352/0367-3057.5.23.08.
- 11. Kuchekar M, Upadhye M, Kulkarni A, Zambare A, Shirke D, Kore P. Verbena officinalis (Verbenaceae): pharmacology, toxicology and role in female health. Int J Ayurvedic Med. 2022;13(2):296–304. doi: 10.47552/ijam.v13i2.2748.
- 12. De Martino L, Iorio M, Coppola G, Campana A, Savastano C, Fusco BM, et al. Verbena officinalis essential oil and citral as apoptotic inductors in leukocytes of healthy subjects and chronic myeloid leukemic patients. 2008;2:170–175.
- 13. Fentahun M, Ayele YB, Amsalu N, Alemayehu A, Amsalu G. Antibacterial evaluation and phytochemical analysis of selected medicinal plants against some pathogenic enteric bacteria in Gozamin District, Ethiopia. J Pharmacovigil. 2017;5(5):1–6. doi: 10.4172/2329-6887.1000244.
- 14. Đorđevski N, Ćirić A, Gašić UM, Ivanov M, Delnatte A, Bechelany M, et al. Electrospun nanofibers loaded with Verbena officinalis extract as multifunctional bioactive wound dressings. Pharmaceuticals (Basel). 2026;19(8):1278. doi: 10.3390/ph19081278.
- 15. Kaur J, Kumar D, Madaan R, Kumar S. Estimation of isolated triterpenoid—ursolic acid in Verbena officinalis L. aerial parts using TLC densitometry. 2014;2(2):121–135. doi: 10.15415/JPTRM.2014.22008.
- 16. Yang J, Guo CS, Su L, Xu CX, Li RT, Zhong JD. Four undescribed triterpenes from the aerial parts of Verbena officinalis. Fitoterapia. 2023;Article 105670. doi: 10.1016/j.fitote.2023.105670.
- 17. Khan AW, Khan AU, Ahmed T. Anticonvulsant, anxiolytic, and sedative activities of Verbena officinalis. Front Pharmacol. 2016;7:499. doi: 10.3389/fphar.2016.00499.
- 18. Dudai N, Weinstein Y, Krup M, Rabinski T, Ofir R. Citral is a new inducer of caspase-3 in tumor cell lines. 2005. doi: 10.1055/s-2005-864146.
- 19. Ghasemi M, Turnbull T, Sebastian S, Kempson I. The MTT assay: utility, limitations, pitfalls, and interpretation in bulk and single-cell analysis. Int J Mol Sci. 2021;22(23):12827. doi: 10.3390/ijms222312827.
- 20. Eloff JN. Avoiding pitfalls in determining antimicrobial activity of plant extracts and publishing the results. BMC Complement Altern Med. 2019;19:106. doi: 10.1186/s12906-019-2519-3.
- 21. Klančnik A, Piskernik S, Jeršek B, Smole Možina S. Evaluation of diffusion and dilution methods to determine the antibacterial activity of plant extracts. J Microbiol Methods. 2010;81(2):121–126. doi: 10.1016/j.mimet.2010.02.004.